Funder
Ministry of Science and Technology, Taiwan
National Taiwan University Hospital
National Taiwan University
Subject
Drug Discovery,Pharmacology
Reference63 articles.
1. Hallmarks of cancer: new dimensions;Hanahan;Cancer Discov,2022
2. The promise and challenges of immune agonist antibody development in cancer;Mayes;Nat Rev Drug Discov,2018
3. US FDA. Oncology (Cancer)/Hematologic Malignancies Approval Notifications. www.fda.gov/drugs/resources-information-approved-drugs/oncology-cancer-hematologic-malignancies-approval-notifications [Accessed 16 January, 2024].
4. Fundamental mechanisms of immune checkpoint blockade therapy;Wei;Cancer Discov,2018
5. A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes;Paulie;Cancer Immunol Immunother,1985